Corton Capital’s Gossamer Bio GOSS Stock Holding History

Corton Capital’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,912	Closed	-$91K	–	307
2022 Q2	$91K	Buy	+10,912	New	+$84.6K	0.09%	286

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Corton Capital's GOSS Position: Q3 2022 in Review

Corton Capital sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 10,912 shares — an estimated $91K sold.

Corton Capital first reported a position in GOSS in Q2 2022 and held it in 1 quarter. The position peaked at $91K in Q2 2022. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

Corton Capital reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
Corton Capital sold 10,912 Gossamer Bio shares in Q3 2022, an estimated $91K.
Corton Capital first reported a position in Gossamer Bio in Q2 2022 and held it in 1 quarter.
Corton Capital's Gossamer Bio position peaked at $91K in Q2 2022.
160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Corton Capital's 13F filing for Q3 2022, filed 14 Nov 2022.